Ulcerated tophaceous gout
Corresponding Author
Girish K Patel
GK Patel, MBBS, MRCP, MD, Department of Dermatology and Wound Healing, School of Medicine, Cardiff University, Heath Park, Cardiff CF14 4XN, UK
GK Patel, Department of Dermatology and Wound Healing, School of Medicine, Cardiff University, Heath Park, Cardiff CF14 4XN, UKE-mail:[email protected]Search for more papers by this authorWendy L Davies
WL Davies, BSc (Hons), RGN, DN, PGCE, Department of Dermatology and Wound Healing, School of Medicine, Cardiff University, Heath Park, Cardiff CF14 4XN, UK
Search for more papers by this authorPatricia P Price
PP Price, BA (Hons), PhD, AFBPsS Department of Dermatology and Wound Healing, School of Medicine, Cardiff University, Heath Park, Cardiff CF14 4XN, UK
Search for more papers by this authorKeith G Harding
KG Harding, MB, MRCGP, FRCS, Department of Dermatology and Wound Healing, School of Medicine, Cardiff University, Heath Park, Cardiff CF14 4XN, UK
Search for more papers by this authorCorresponding Author
Girish K Patel
GK Patel, MBBS, MRCP, MD, Department of Dermatology and Wound Healing, School of Medicine, Cardiff University, Heath Park, Cardiff CF14 4XN, UK
GK Patel, Department of Dermatology and Wound Healing, School of Medicine, Cardiff University, Heath Park, Cardiff CF14 4XN, UKE-mail:[email protected]Search for more papers by this authorWendy L Davies
WL Davies, BSc (Hons), RGN, DN, PGCE, Department of Dermatology and Wound Healing, School of Medicine, Cardiff University, Heath Park, Cardiff CF14 4XN, UK
Search for more papers by this authorPatricia P Price
PP Price, BA (Hons), PhD, AFBPsS Department of Dermatology and Wound Healing, School of Medicine, Cardiff University, Heath Park, Cardiff CF14 4XN, UK
Search for more papers by this authorKeith G Harding
KG Harding, MB, MRCGP, FRCS, Department of Dermatology and Wound Healing, School of Medicine, Cardiff University, Heath Park, Cardiff CF14 4XN, UK
Search for more papers by this authorAbstract
Gout is often considered a disease of an excessive lifestyle, a ‘malady of kings'. Today, more than 1% of the European and US populations are afflicted with gout, although ulceration over gout tophi remains uncommon. We describe four cases of ulceration associated with gout tophi to highlight the clinical presentation, complications and a management strategy.
REFERENCES
- 1 Harris CM, Lloyd DC, Lewis J. The prevalence and prophylaxis of gout in England. J Clin Epidemiol 1995; 48: 1153–8.
- 2 Annemans L, Spaepen E, Gaskin M, Bonnemaire M, Malier V, Gilbert T, Nuki G. Gout in the UK and Germany: prevalence, comorbidities and management in general practice 2000–2005. Ann Rheum Dis 2008; 67: 960–6.
- 3 Doherty M. New insights into the epidemiology of gout. Rheumatology 2009; 48: 2–8.
- 4 Wallace K, Riedel A, Joseph-Ridge N, Wortmann R. Increasing prevalence of gout and hyperuricaemia over 10 years among older adults in a managed care population. J Rheumatol 2004; 31: 1582–7.
- 5 Richette P, Bardin T. Gout. Lancet 2009; 6737: 60833–7.
- 6 De Leonardis F, Govoni M, Colina M, Bruschi M, Trotta F. Elderly-onset gout: a review. Rheumatol Int 2007; 28: 1–6.
- 7 Schumacher Jr HR, Becker MA, Palo WA, Streit J, MacDonald PA, Joseph-Ridge N. Topheaceous gout: quantitative evaluation by direct physical measurement. J Rheumatol 2005; 32: 2368–72.
- 8 Price P, Harding K. Cardiff wound impact schedule: the development of a condition-specific questionnaire to assess health-related quality of life in patients with chonic wounds of the lower limb. Int Wounds J 2004; 1: 10–7.
- 9 Choi HK, Artkinson K, Karlson EW, Willett W, Curhan G. Purine-rich foods, dairy and protein intake, and the risk of gout in men. N Engl J Med 2004; 350: 1093–103.
- 10 Brulé D, Sarwar G, Savoie L. Changes in serum and urinary uric acid levels in normal human subjects fed purine-rich foods containing different amounts of adenine and hypoxanthine. J Am Coll Nutr 1992; 11: 353–8.
- 11 Liebman SE, Taylor JG, Bushinsky DA. Uric acid nephrolithiasis. Curr Rheum Rep2007; 9: 251–7.
- 12 Choi HK, Mount DB, Reginato AM. Pathogenesis of gout. Ann Intern Med 2005; 143: 499–516.
- 13 Enomoto A, Kimura H, Chairoungdua A, Shigeta Y, Jutabha P, Cha SH, Hosoyamada M, Takeda M, Sekine T, Igarashi T, Matsuo H, Kikuchi Y, Oda T, Ichida K, Hosoya T, Shimokata K, Niwa T, Kanai Y, Endou H. Molecular identification of a renal urate anion exchanger that regulates blood urate levels. Nature 2002; 417: 447–52.
- 14 Vitart V, Rudan I, Hayward C, Gray NK, Floyd J, Palmer CN, Knott SA, Kolcic I, Polasek O, Graessler J, Wilson JF, Marinaki A, Riches PL, Shu X, Janicijevic B, Smolej-Narancic N, Gorgoni B, Morgan J, Campbell S, Biloglav Z, Barac-Lauc L, Pericic M, Klaric IM, Zgaga L, Skaric-Juric T, Wild SH, Richardson WA, Hohenstein P, Kimber CH, Tenesa A, Donnelly LA, Fairbanks LD, Aringer M, McKeigue PM, Ralston SH, Morris AD, Rudan P, Hastie ND, Campbell H, Wright AF. SLC2A9 is a newly identified urate transporter influencing serum urate concetration, urate excretion and gout. Nat Genet 2008; 40: 437–42.
- 15 Stein R. The genetic basis of uric acid variance. Clin Genet 2008; 74: 410–3.
- 16 Martinon F, Petrilli V, Mayor A, Tardivel A, Tschopp J. Gout-associateed uric acid crystals activate the NALP3 inflammasome. Nature 2006; 440: 237–41.
- 17 Ng G, Sharma K, Ward SM, Desrosiers MD, Stephens LA, Schoel WM, Li T, Lowell CA, Ling CC, Amrein MW, Shi Y. Receptor-independent, direct membrane binding leads to cell-surface lipid sorting and Syk kinase activation in dendritic cells. Immunity 2008; 29: 807–18.
- 18 O’Duffy JD, Hunder GG, Kelly PJ. Decreasing prevalence of tophaceous gout. Mayo Clin Proc 1975; 50: 227–8.
- 19 Lawry GV, Fan PT, Bluestone R. Polyarticular versus monoarticular gout: a prospective, comparative analysis of clinical features. Medicine 1988; 67: 335–43.
- 20 Wernick R, Winkler C, Campbell S. Tophi as the initial presentation of gout. Arch Intern Med 1992; 152: 873–6.
- 21 Ter Borg EJ, Rasker JJ. Gout in the elderly, a separate entity? Ann Rheum Dis 1987; 46: 72–6.
- 22 Palmer DG, Highton J, Hessian PA. Development of the gout tophus. Am J Clin Pathol 1989; 91: 190–5.
- 23 Lucke TW, Fallowfield ME, Evans A et al. Transepidermal elimination of urate-like crystals: a new perforating disorder? Br J Dermatol 1999; 141: 310–4.
- 24 Choi HK, Artkinson K, Karlson EW, Curhan G. Obesity, weight change, hypertension, diuretic use, and risk of gout in men: the health professionals follow-up study. Arch Intern Med 2005; 165: 742–8.
- 25 Culleton BF, Larson MG, Kannel WB, Levy D. Serum uric acid and risk for cardiovascular disease death: the Framingham Heart Study. Ann Intern Med 1999; 131: 7–13.
- 26 Niskanen LK, Laaksonen DE, Nyyssonen K et al. Uric acid levels as a risk factor for cardiovascular and all-cause mortality in middle-aged men: a prospective cohort study. Arch Intern Med 2004; 164: 1546–51.
- 27 Rho YH, Choi SJ, Lee YH et al. The prevalence of metabolic syndrome in patients with gout: a multi center study. J Korean Med Sci 2005; 20: 1029–33.